成都先导：预计2025年年度净利润为1.04亿元~1.27亿元，同比增加102.5%~147.29%

Group 1 - The company Chengdu XianDao expects a net profit attributable to shareholders of 104 million to 127 million yuan for the year 2025, representing an increase of 52.64 million to 75.64 million yuan compared to the previous year, which is a year-on-year increase of 102.5% to 147.29% [1] - The main reason for the performance change is the impact of the core business, with steady growth in the DEL business, which maintains a high gross margin, contributing to overall profit improvement [1] - The UK subsidiary has further consolidated the steady development of the FBDD/SBDD platform, with revenue from major business segments showing steady growth and milestone revenue achieved from DEL and FBDD/SBDD client projects [1] Group 2 - The new technology business segment is gradually showing commercial transformation, with the OBT segment expanding traditional nucleoside monomer synthesis while achieving significant year-on-year revenue growth through delivery molecule-related services [1] - The company’s self-designed and built automated high-throughput chemical synthesis platform is operating efficiently, driving year-on-year revenue growth in ChemSer [1] - The steady growth in main business revenue and simultaneous improvement in gross margin have led to an increase in profits for the reporting period [1]